Christopher Schroeder

2.3k total citations
53 papers, 740 citations indexed

About

Christopher Schroeder is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Christopher Schroeder has authored 53 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Cancer Research and 14 papers in Molecular Biology. Recurrent topics in Christopher Schroeder's work include Cancer Genomics and Diagnostics (15 papers), CAR-T cell therapy research (9 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Christopher Schroeder is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), CAR-T cell therapy research (9 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Christopher Schroeder collaborates with scholars based in Germany, United States and Spain. Christopher Schroeder's co-authors include Peter Bauer, Marc Sturm, Cihan Gani, Olaf Rieß, Stephan Ossowski, Daniel Zips, Bernhard Berger, Franz J. Hilke, German Demidov and Irina Bonzheim and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Christopher Schroeder

47 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Schroeder Germany 17 308 249 162 153 112 53 740
Enrico Berrino Italy 16 394 1.3× 270 1.1× 128 0.8× 271 1.8× 170 1.5× 42 849
Letizia Perracchio Italy 16 315 1.0× 382 1.5× 110 0.7× 168 1.1× 80 0.7× 33 801
Iris Tischoff Germany 16 403 1.3× 422 1.7× 164 1.0× 155 1.0× 55 0.5× 54 1.1k
Antreas Hindoyan United States 11 365 1.2× 409 1.6× 93 0.6× 128 0.8× 48 0.4× 24 767
Elisa Gruppioni Italy 15 216 0.7× 274 1.1× 155 1.0× 136 0.9× 37 0.3× 56 703
Virginie Ory United States 12 288 0.9× 401 1.6× 248 1.5× 128 0.8× 31 0.3× 16 923
Kristen E. Muller United States 15 275 0.9× 196 0.8× 77 0.5× 162 1.1× 57 0.5× 42 587
Harriette Kahn Canada 15 365 1.2× 375 1.5× 95 0.6× 222 1.5× 136 1.2× 23 864
Stefania Berton Italy 16 405 1.3× 400 1.6× 66 0.4× 265 1.7× 64 0.6× 28 858
Aaron M. Gruver United States 16 376 1.2× 329 1.3× 194 1.2× 162 1.1× 84 0.8× 38 762

Countries citing papers authored by Christopher Schroeder

Since Specialization
Citations

This map shows the geographic impact of Christopher Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Schroeder more than expected).

Fields of papers citing papers by Christopher Schroeder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Schroeder. The network helps show where Christopher Schroeder may publish in the future.

Co-authorship network of co-authors of Christopher Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Schroeder. A scholar is included among the top collaborators of Christopher Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Schroeder. Christopher Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ott, A., Irina Bonzheim, Dominik Nann, et al.. (2025). Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion. Frontiers in Oncology. 15. 1527484–1527484. 2 indexed citations
2.
Abele, Michael, Ulrike Faust, Sorin Armeanu–Ebinger, et al.. (2025). Distinct genomic profile of pediatric lung carcinoma: High frequency of ALK fusions and TP53 mutations compared to adults. Lung Cancer. 209. 108800–108800. 1 indexed citations
3.
Elbracht, Miriam, Bernd Auber, Ingo Kurth, et al.. (2024). Humangenetische Diagnostik bei onkologischen Erkrankungen. 30(10). 922–931.
4.
Rieß, Olaf, Marc Sturm, German Demidov, et al.. (2024). Genomes in clinical care. npj Genomic Medicine. 9(1). 20–20. 11 indexed citations
5.
Schroeder, Christopher, et al.. (2024). Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic. Urologic Oncology Seminars and Original Investigations. 42(3). 72.e19–72.e25.
6.
Schroeder, Christopher, Sergios Gatidis, Olga Kelemen, et al.. (2024). Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition. Nature Communications. 15(1). 8750–8750. 12 indexed citations
7.
Forchhammer, Stephan, Christian Seitz, Christopher Schroeder, et al.. (2024). Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma. Pigment Cell & Melanoma Research. 37(4). 453–461. 3 indexed citations
8.
Amaral, Teresa, Oltin T. Pop, Tobias Sinnberg, et al.. (2023). EGFR expression and relapse in patients with melanoma receiving adjuvant PD-1-based immunotherapy.. Journal of Clinical Oncology. 41(16_suppl). e21566–e21566. 1 indexed citations
9.
Deniz, Miriam, Ulrike Faust, Cristiana Roggia, et al.. (2023). ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways—lessons from breast cancer patients. Cell Death and Disease. 14(5). 328–328. 1 indexed citations
10.
Faust, Ulrike, Gertrud Strobl‐Wildemann, Marc Sturm, et al.. (2023). Genome sequencing identifies complex structural MLH1 variant in unsolved Lynch syndrome. Molecular Genetics & Genomic Medicine. 11(6). e2151–e2151. 3 indexed citations
11.
Schroeder, Christopher, Olga Kelemen, Tobias Engler, et al.. (2022). 2022-RA-1048-ESGO Circulating HPV cell-free DNA in cervical cancer. International Journal of Gynecological Cancer. 32. A40–A40. 1 indexed citations
12.
Schroeder, Christopher, Peter Martus, Sorin Armeanu–Ebinger, et al.. (2022). TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy. Journal of Cancer Research and Clinical Oncology. 149(2). 833–840. 13 indexed citations
13.
Hilke, Franz J., Francesc Muyas, Jakob Admard, et al.. (2020). Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy. Radiotherapy and Oncology. 151. 182–189. 39 indexed citations
14.
Hilke, Franz J., Tobias Sinnberg, Heike Niessner, et al.. (2020). Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients. Cancers. 12(9). 2359–2359. 37 indexed citations
15.
Leibfarth, Sara, Franz J. Hilke, Jakob Admard, et al.. (2020). PET/MRI and genetic intrapatient heterogeneity in head and neck cancers. Strahlentherapie und Onkologie. 196(6). 542–551. 10 indexed citations
16.
Blaeschke, Franziska, Milan Paul, Martin U. Schuhmann, et al.. (2019). Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy. Cytotherapy. 21(9). 973–986. 31 indexed citations
17.
Lohmann, Ebba, Marc Sturm, Florian Lenz, et al.. (2019). Single Molecule Molecular Inversion Probes for High Throughput Germline Screenings in Dystonia. Frontiers in Neurology. 10. 1332–1332. 2 indexed citations
18.
Bonzheim, Irina, Claudia Dufke, Thomas Hentrich, et al.. (2017). Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia. PLoS ONE. 12(6). e0178503–e0178503. 14 indexed citations
19.
Kohlbacher, Oliver, Rupert Handgretinger, Hans‐Georg Rammensee, et al.. (2013). iVacALL: utilizing next-generation sequencing for the establishment of an individual peptide vaccination approach for paediatric acute lymphoblastic leukaemia. Bone Marrow Transplantation. 48(3). 2 indexed citations
20.
Hoeger, Peter H., B. Niggemann, & Christopher Schroeder. (1992). Enhanced basal and stimulated PMN chemiluminescence activity in children with atopic dermatitis: stimulatory role of colonizing staphylococci?. Acta Paediatrica. 81(6-7). 542–546. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrico Berrino Breakdown of academic impact, for papers by Letizia Perracchio Breakdown of academic impact, for papers by Iris Tischoff Breakdown of academic impact, for papers by Antreas Hindoyan Breakdown of academic impact, for papers by Elisa Gruppioni Breakdown of academic impact, for papers by Virginie Ory Breakdown of academic impact, for papers by Kristen E. Muller Breakdown of academic impact, for papers by Harriette Kahn Breakdown of academic impact, for papers by Stefania Berton Breakdown of academic impact, for papers by Aaron M. Gruver
Rankless by CCL
2026